Table 2.
Association between serum magnesium level and MCI among HD patients.
| Serum magnesium (mmol/L) | Model 1 |
Model 2 |
Model 3 |
|||
|---|---|---|---|---|---|---|
| OR (95%CI) | P-value | OR (95%CI) | P-value | OR (95%CI) | P-value | |
| MCI | ||||||
| Q1 (0.41–0.83) | 1.97 (1.43–2.72) | <0.001 | 1.79 (1.29–2.48) | <0.001 | 1.55 (1.10–2.18) | 0.012 |
| Q2 (0.84–1.04) | 1.28 (1.06–1.55) | 0.010 | 1.19 (0.98–1.44) | 0.077 | 1.15 (0.94–1.40) | 0.176 |
| Q3 (1.05–1.18) | 1.01 (0.83–1.28) | 0.941 | 0.98 (0.80–1.20) | 0.860 | 0.97 (0.79–1.19) | 0.753 |
| Q4 (1.19–1.45) | Reference | Reference | Reference | |||
| Q5 (1.46–2.78) | 1.30 (0.92–1.83) | 0.133 | 1.32 (0.93–1.87) | 0.118 | 1.32 (0.93–1.87) | 0.126 |
Note: P < 0.05 was considered statistically significant. Abbreviations: HD: hemodialysis; OR: odds ratio; CI: confidence interval; MCI: mild cognitive impairment. Model 1: no adjustment; Model 2: adjusted for age and sex; Model 3: adjusted for age, sex, smoking, working, educational level, living status, Hypertension, diabetes, cerebrovascular disease, mean arterial pressure, waist-hip circumference ratio, serum urid acid, iPTH, and hs-CRP levels.